Novo Nordisk Invests $158 Million to Upgrade Brazilian Insulin Plant

Novo Nordisk, a Danish pharmaceutical company, will invest $158.2 million to modernize its insulin production plant in Montes Claros, Brazil. The investment will upgrade equipment and implement sustainability initiatives. This announcement coincided with a meeting between the Brazilian President and the Queen of Denmark.